Diabetes News and Research

Latest Diabetes News and Research

Gut hormone-drug combination therapy more effective at improving type 2 diabetes

Combined treatment with a drug that mimics the action of a gut hormone and basal insulin is more effective at improving blood sugar control than other anti-diabetic treatments, with similar rates of hypoglycaemia (dangerously low blood sugar levels) and greater weight loss, a systematic review and meta-analysis published in The Lancet shows.

15 Sep 2014

GILZ protein key to preventing bone loss, researchers report

A small protein named GILZ appears to protect against the bone loss that often accompanies arthritis and its treatment, researchers report.

15 Sep 2014

Health value of Apple's Watch questioned

Health care professionals say there is little evidence the new watch surpasses gadgets already on the market, although more health features may be in store, Reuters reports. Meanwhile, The Associated Press examines tensions between Silicon Valley tech giants and government regulators.

15 Sep 2014

Researchers report that dendritic cells can affect psoriasis

Different types of dendritic cells in human skin have assorted functions in the early and more advanced stages of psoriasis report researchers in the journal EMBO Molecular Medicine.

15 Sep 2014

Study: High-dose prescribing increases by 23% in Canada

High-dose opioid prescribing increased by 23 per cent in Canada between 2006 and 2011, despite clinical guidelines recommending that most patients should avoid high-doses of these drugs, according to new research.

15 Sep 2014

ChromaDex signs NIAGEN supply agreement with Healthy Directions

ChromaDex Corp., an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, cosmetic and pharmaceutical industries, announced today that it has entered into an ingredient supply agreement with Healthy Directions, a direct-to-consumer nutritional supplement retailer and wholly-owned subsidiary of Helen of Troy Limited.

11 Sep 2014

New collaborative approach could help improve diabetes care in China

Diabetes has become a major public health crisis in China, with an annual projected cost of 360 billion RMB (nearly 35 billion British pounds) by 2030, but a new collaborative approach to care that uses registries and community support could help improve diabetes care, according to a new three-part Series about diabetes in China published in The Lancet Diabetes & Endocrinology.

11 Sep 2014

FDA approves Contrave extended-release tablets for chronic weight management

Takeda Pharmaceuticals U.S.A., Inc. and Orexigen® Therapeutics, Inc. jointly announced today that the U.S. Food and Drug Administration has approved Contrave® extended-release tablets as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index of 30 kg/m2 or greater (obese), or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition.

11 Sep 2014

HolaDoctor launches new Interactive Health Insurance Center to educate Hispanics

HolaDoctor.com, the leading health website in the Hispanic digital market, launched a new Interactive Health Insurance Center which aims to inform and educate Hispanics on how to apply for and acquire health coverage in 2015.

11 Sep 2014

New research shows statins could reduce common diabetes complications

The development of common diabetes complications that can lead to blindness and amputations could be reduced by taking statins, indicates new research published in The Lancet Diabetes & Endocrinology.

11 Sep 2014

Professor receives award for development of anti-angiogenic therapy for retinal disease

Napoleone Ferrara, MD, distinguished professor of pathology and distinguished adjunct professor of ophthalmology at the University of California, San Diego School of Medicine and senior deputy director for basic sciences at UC San Diego Moores Cancer Center, was named today as one of seven recipients of the Ant-nio Champalimaud Vision Award in Lisbon, Portugal.

11 Sep 2014

Clinical trial of stem cell-derived therapy for patients with Type 1 diabetes

Researchers at the University of California, San Diego School of Medicine, in partnership with ViaCyte, Inc., a San Diego-based biotechnology firm specializing in regenerative medicine, have launched the first-ever human Phase I/II clinical trial of a stem cell-derived therapy for patients with Type 1 diabetes.

11 Sep 2014

Study looks at blood type and risk of cognitive impairment

People with blood type AB may be more likely to develop memory loss in later years than people with other blood types, according to a study published in the September 10, 2014, online issue of Neurology®, the medical journal of the American Academy of Neurology.

11 Sep 2014

Food commercials 'get under the skin' of teens by activating reward regions

Children and adolescents see thousands of food commercials each year and most of them advertise junk foods high in sugar, fat and salt.

11 Sep 2014

Continuing to work during depressive illness may offer employees certain health benefits

The collaborative study between the University Of Melbourne and the Menzies Research Institute at the University of Tasmania is the first to estimate the long-term costs and health outcomes of depression-related absence as compared to individuals who continue to work among employees with depression in Australia.

11 Sep 2014

Diabetes News and Research

Latest Diabetes News and Research

Gut hormone-drug combination therapy more effective at improving type 2 diabetes

GILZ protein key to preventing bone loss, researchers report

Health value of Apple's Watch questioned

Researchers report that dendritic cells can affect psoriasis

Study: High-dose prescribing increases by 23% in Canada

ChromaDex signs NIAGEN supply agreement with Healthy Directions

New collaborative approach could help improve diabetes care in China

FDA approves Contrave extended-release tablets for chronic weight management

HolaDoctor launches new Interactive Health Insurance Center to educate Hispanics

New research shows statins could reduce common diabetes complications

Professor receives award for development of anti-angiogenic therapy for retinal disease

Clinical trial of stem cell-derived therapy for patients with Type 1 diabetes

Study looks at blood type and risk of cognitive impairment

Food commercials 'get under the skin' of teens by activating reward regions

Continuing to work during depressive illness may offer employees certain health benefits

People with diabetes may have six-fold higher risk of developing heart failure

Researchers find that people suffering from sleep apnea have weaker brain blood flow

Dell, Terascala and TGen to install genomic data management solution at NCI

Lilly and Boehringer Ingelheim's insulin glargine product gets marketing approval from EC

Sanofi contributes $2.5 million to CCNA for dementia research

Genomics - Industry Focus eBook (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Diabetes News and Research

Latest Diabetes News and Research

Genomics - Industry Focus eBook (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in